Glaxo is conducting a randomized

July 10, 2010 by Philbert Ross · Leave a Comment
Filed under: FDA 

While the IOM did not target the Avandia trial in particular, FDA Commissioner Margaret Hamburg asked the independent, nonprofit medical group to weigh in with at least an initial finding on general ethical issues involving the safety of studying the risks of drugs already in use.
The FDA called in 2007 for the TIDE study, which [...]

Fda said research showed mixing antibiotics livestock

June 29, 2010 by Aleccia Yule · Leave a Comment
Filed under: FDA 

Over-the-counter antibiotics have been routinely used for decades to promote livestock growth and feed efficiency.
Emergence of antibiotic-resistant bacteria poses a serious public health threat, said FDA, so it is looking for ways to reduce overuse of the drugs.
Antibiotics including penicillin and tetracyclines should be used only under the supervision of veterinarians to prevent or [...]

The information comes part from post approval reports

June 16, 2010 by Philbert Ross · Leave a Comment
Filed under: FDA 

The information comes in part from post-approval reports of health problems from consumers, doctors and companies, Food and Drug Administration officials said as they unveiled the program on Tuesday. Agency reviewers also look at medical literature and ongoing studies.
The FDA and companies track potential problems after a drug reaches the market as some side effects [...]

One memo under logo of mcneil consumer healthcare

June 12, 2010 by Johnson Anders · Leave a Comment
Filed under: FDA 

Simply visit each store, locate the product and, if any is found, purchase all of the product.
The Motrin recall came to light during a congressional hearing concerning JampJs widespread April recall of its Tylenol, Motrin, Benadryl and Zyrtec products for infants and children.
As part of its investigation into the April recall, the U.S. House [...]

In page warning letter pfizer chief executive jeffrey

June 10, 2010 by Editor · Leave a Comment
Filed under: FDA 

In a 12-page warning letter to Pfizer Chief Executive Jeffrey Kindler, the FDA cited numerous examples involving some of the companys top-known brands, including impotence drug Viagra, cholesterol pill Lipitor and seizure medicine Lyrica.
The delays in reporting side effects date back as far as 2004 and have grown in recent years, according to the [...]

The food and drug administration does not consider

May 27, 2010 by Johnson Anders · Leave a Comment
Filed under: FDA 

At this time, FDA is not aware of any child being harmed by taking one of the recalled products, said the staff report, dated May 24. FDA is still investigating some of these adverse events to determine if the events were related to a child taking one of the recalled medicines.
Since the April 30 recall, [...]

Fda may disclose more details on drug, food safety

May 20, 2010 by Aleccia Yule · Leave a Comment
Filed under: FDA 

The effort is part of a broader plan to remake the public image of the Food and Drug Administration, which has come under fire for being too secretive.
An agency taskforce is suggesting 21 ways the FDA could release more information to the public in areas like drug evaluation and in food manufacturing inspections, [...]

Fda inspectors found lax testing for contamination at j&js tylenol production site

May 10, 2010 by Johnson Anders · Leave a Comment
Filed under: FDA 

Agency officials said Tuesday none of the companys finished products tested positive for the contaminants, though such testing is not definitive.
We think the risk to consumers at this point is remote, said Deborah Autor, director of FDAs drug compliance office, on a call with reporters.
The FDA report, which was posted online, lists [...]

Fda Discovered Bacteria In Lots For Recalled Tylenol

May 5, 2010 by Philbert Ross · Leave a Comment
Filed under: FDA 

Agency officials said Tuesday none of the companys finished products tested positive for the contaminants, though such testing is not definitive.
“We think the risk to consumers at this point is remote,” said Deborah Autor, director of FDAs drug compliance office, on a call with reporters.
The FDA report, which was posted online, lists more than 20 [...]

Fda Stepping Up Supervision Of Drug Pumps

April 24, 2010 by Aleccia Yule · Leave a Comment
Filed under: FDA 

“Its clear from the history of problems were seeing that there is a need for more careful infusion pump design and testing,” said Dr. Jeffrey Shuren of the U.S. Food and Drug Administration. He announced the initiative Friday at a health journalists conference in Chicago.
Infusion pumps are used to deliver fluids – liquid nutrients and [...]

Next Page »